C5AR1 and neoplasm: Among them, intratumoral complement 5a (C5a) is increased in patients with CRC after radiotherapy [5], which can suppress cytotoxic T-cell function by recruiting myeloid-derived suppressor cells (MDSCs) to the tumor microenvironment [6], thereby augmenting inflammation-mediated intestinal tumorigenesis [7].